What is Rupa?
Rupa operates at the intersection of health-tech and clinical diagnostics, providing a comprehensive telehealth solution designed to streamline the ordering and interpretation of functional lab tests. By leveraging proprietary technology, the platform enables practitioners to deliver personalized care without sacrificing the human element of the patient-provider relationship. Rupa effectively acts as a digital backbone for functional medicine clinics, simplifying administrative burdens and enhancing the accessibility of specialized health insights. Its market position is defined by its ability to integrate disparate diagnostic workflows into a unified, user-friendly interface, thereby addressing a significant pain point in the modern healthcare landscape.
How much funding has Rupa raised?
Rupa has raised a total of $25.8M across 2 funding rounds:
Angel/Seed
$5.8M
Series A
$20M
Angel/Seed (2021): $5.8M with participation from Floodgate, First Round Capital, and SV Angel
Series A (2022): $20M led by Bessemer Venture Partners and First Round Capital
Key Investors in Rupa
Floodgate
Floodgate is a venture capital firm specializing in early-stage investments, focusing on identifying and supporting pattern-breaking founders in the technology sector.
First Round Capital
First Round is a prominent early-stage venture firm that provides startups with tailored programs, community resources, and expert advice to facilitate successful company building.
Bessemer Venture Partners
Bessemer Venture Partners is a global venture capital firm with a long history of supporting transformative companies across various stages of growth.
What's next for Rupa?
With the recent infusion of $20M, Rupa is well-positioned to accelerate its product development and expand its footprint within the digital health ecosystem. The strategic focus will likely center on scaling its laboratory network, enhancing its diagnostic software capabilities, and deepening its integration with existing electronic health record systems. As the demand for personalized, data-driven healthcare continues to rise, Rupa's ability to maintain its human-centric service model while scaling its technical infrastructure will be the primary driver of its long-term competitive advantage. Investors are closely watching how the company utilizes this capital to capture a larger share of the functional medicine market and establish itself as the industry standard for diagnostic-led telehealth.
See full Rupa company page
